1. Frontier Biotech press release. Frontier Biotech Receives Marketing Authorization from China FDA for Aikening (Albuvirtide for Injection) China's first new drug for the treatment of HIV. (06 June 2018).http://www.frontierbiotech.com/en/news
2. Wu H.;Yao C.;Lu R. J.Albuvirtide the first long‐acting HIV fusion inhibitor suppressed viral replication in HIV‐infected adults. 52nd Interscience Conference on Antimicrobials and Chemotherapy (ICAAC). September 9–12 2012. San Francisco. Abstract H‐554.
3. Potent suppression of HIV‐1 replication in humans by T‐20, a peptide inhibitor of gp41‐mediated virus entry;Kilby J. M.;Nat. Med.,1998
4. TORO 1 Study Group. Enfuvirtide, an HIV‐1 fusion inhibitor, for drug‐resistant HIV infection in North and South America;Lalezari J. P.;N. Engl. J. Med.,2003
5. FDA. FDA Approves Fuzeon. Available from:http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm125088.htm2003.